All data are based on the daily closing price as of December 5, 2024
p

PharmaResearch

214450.KQ
154.99 USD
1.63
+1.06%

Overview

Last close
154.99 usd
Market cap
1.60B usd
52 week high
169.94 usd
52 week low
67.66 usd
Target price
199.65 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
7.8996
Price/Book Value
4.4518
Enterprise Value
1.45B usd
EV/Revenue
6.5806
EV/EBITDA
16.5311

Key financials

Revenue TTM
209.42M usd
Gross Profit TTM
99.92M usd
EBITDA TTM
83.19M usd
Earnings per Share
N/A usd
Dividend
0.67 usd
Total assets
601.47B usd
Net debt
N/A usd

About

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration; Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; and Rejuvenex cream, which treats the wound through rapid tissue regeneration. It also provides REJURAN, a medical device for face (especially eye, perioral area), neck, Décolleté, hands, etc; CLEVIEL prime plus and contour plus with lidocaine medical devices; D+CELL 350 TRA I; and REJURAN moisturizer for daily skin protection, as well as REJUVENEX SCULPT V; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. In addition, the company offers D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; REJURAN FORTE; and CONJURAN medical devices. Further, it offers functional foods; and engages in the development of software and consulting businesses. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Gangneung-si, South Korea.
  • Symbol
    214450.KQ
  • Exchange
    KQ
  • Isin
    KR7214450009
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Mr. Sang-Soo Jung
  • Headquarter
    Gangneung-si
  • Web site
    https://www.pharmaresearch.co.kr/kor/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top